Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects

Clinical trial NCT01565681 · COMPLETED

Trial details

NCT number: NCT01565681
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASKP1240 Healthy Volunteers

Start date: 2009-01-01
Primary completion: 2009-12-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.